Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function.

Background: Colistimethate sodium (CMS) treatment has increased over the last years, being acute kidney injury (AKI) its main drug-related adverse event. Therefore, this study aimed to evaluate the incidence and risk factors associated with AKI, as well as identifying the factors that determine renal function (RF) outcomes at six months after discharge.

Materials And Methods: This retrospective study included adult septic patients receiving intravenous CMS for at least 48h (January 2007-December 2014).

Outcomes of Peritoneal Dialysis Catheter Left In Place after Kidney Transplantation.

No clear consensus has been reached regarding the optimal time to remove the peritoneal dialysis catheter (PDC) after kidney transplantation (KT). This retrospective observational study, conducted in a single peritoneal dialysis (PD) unit including all PD patients who received a KT between 1995 - 2015, was undertaken to evaluate the clinical outcomes and potential complications associated with a PDC left in place after KT. Of the 132 PD patients who received a KT, 20 were excluded from the study.